|4Jun 6, 4:15 PM ET

DOUGLAS RICHARD 4

4 · Aldeyra Therapeutics, Inc. · Filed Jun 6, 2024

Insider Transaction Report

Form 4
Period: 2024-06-04
Transactions
  • Award

    Stock Option (Right to Buy)

    2024-06-04+40,28240,282 total
    Exercise: $4.09Exp: 2034-06-03Common Stock (40,282 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-06-04+1,2151,215 total
    Exercise: $4.09Exp: 2034-06-03Common Stock (1,215 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-06-04+10,41810,418 total
    Exercise: $4.09Exp: 2034-06-03Common Stock (10,418 underlying)
Footnotes (3)
  • [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
  • [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date.
  • [F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4